Please login to the form below

Not currently logged in
Email:
Password:

Antares Pharma

This page shows the latest Antares Pharma news and features for those working in and with pharma, biotech and healthcare.

A matter of urgency

It bought the anticholinergic, Toviaz (fesoterodine) for over $100 million in April 2006 from German company Schwarz Pharma. ... One such is Antares Pharma's Anturol, shown in phase II studies to lead to only minimal dry mouth.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Antares CEO Wotton resigns Antares CEO Wotton resigns

    He will move to Advanced Cell Technology. Antares Pharma CEO Paul Wotton is to resign his position to take over as CEO at development-stage biotech company Advanced Cell Technology. ... His replacement at Antares is Eamonn Hobbs, a current board member

  • Antares appoints David Bergstrom as SVP Antares appoints David Bergstrom as SVP

    Second major appointment in one month. Antares Pharma has appointed Dr David Bergstrom as senior VP of pharmaceutical development. ... He is the second senior VP to join Antares this month after the appointment of former Pfizer VP Dr Bruce Freundlich as

  • Former Pfizer VP joins Antares Former Pfizer VP joins Antares

    Bruce Freundlich appointed senior VP, medical. Antares Pharma has appointed Dr Bruce Freundlich as senior VP, medical. ... Antares Pharma has made several senior appointments in the past year, including a new VP, clinical development, and senior VP,

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....